Search

everythinglearnresearchcommunity

for

Search:↓

Black cumin and its nanoformulations show promise in treating neurodegenerative diseases.

Plant adaptogens may help treat skin diseases and improve skin health, but more research is needed to fully understand how they work.

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

Different types of resting melanocyte stem cells have unique characteristics and vary in their potential to become other cells.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Iris germanica rhizome-derived exosomes help protect skin cells from oxidative stress and aging.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Olfactory receptors found outside the nose may offer new treatments for diseases like cancer and help in wound healing and hair growth.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

A man's bald spot grew hair after starting cancer treatment with gefitinib.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

c-kit affects hair growth and color in alopecia areata and androgenetic alopecia.

People with alopecia have shorter hair follicles and more c-kit, a stem cell factor receptor, which could predict how the condition progresses.

Decorin, a protein, may help start hair growth and could be used to treat hair loss.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

Oxytocin receptors are found in skin cells near touch and pain neurons.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Blue-light activation of TrkA improves hair-follicle stem cells' ability to become neurons and glial cells.

ERG increases SOX9, promoting prostate cancer growth and invasion.